Outpatient Treatment With Anti-Coronavirus Immunoglobulin

Recruiting

Phase 3

Outpatient Treatment With Anti-Coronavirus ImmunoglobulinOutpatient Treatment With Anti-Coronavirus Immunoglobulin

Sponsor:

University of Minnesota

Code:

NCT04910269

Conditions

COVID

SARS-CoV2 Infection

Covid19

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of Minnesota on 2025-03-25.